PRESS RELEASE published on 09/02/2025 at 22:15, 1 year ago Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF published on 08/27/2025 at 08:05, 1 year ago Nanobiotix Announces Voting Rights and Shares Capital Update Euronext Paris Voting Rights Biotechnology Shares Capital NANOBIOTIX
PRESS RELEASE published on 08/27/2025 at 08:00, 1 year ago Voting Rights and Shares Capital of the Company Nanobiotix announces voting rights and shares capital details as per French Commercial Code regulations. The late-stage clinical biotech company focuses on disruptive therapies in oncology, bioavailability, and CNS disorders Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF published on 08/11/2025 at 11:34, 1 year 1 month ago Threshold Crossings by The Goldman Sachs Group, Inc. at Nanobiotix Actions Financial Market Goldman Sachs Crossing Thresholds NANOBIOTIX
BRIEF published on 07/07/2025 at 22:20, 1 year 2 months ago NANOBIOTIX: Reclassification and New Patent for JNJ-1900 (NBTXR3) Patent NANOBIOTIX Regulatory JNJ-1900 Harmonization
PRESS RELEASE published on 07/07/2025 at 22:15, 1 year 2 months ago NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3) Nanobiotix announces regulatory harmonization and new composition of matter patent filed for JNJ-1900 (NBTXR3), aiming to reinforce global positioning of potential first-in-class radioenhancer NANOBIOTIX JNJ-1900 Global Positioning Regulatory Harmonization Composition Of Matter Patent
BRIEF published on 06/24/2025 at 12:39, 1 year 2 months ago Goldman Sachs Crosses Stake Threshold in Nanobiotix Stock Market Acquisition Of Shares Goldman Sachs Threshold Crossing NANOBIOTIX
BRIEF published on 06/10/2025 at 22:20, 1 year 3 months ago Number of Shares and Voting Rights of Nanobiotix Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE published on 06/10/2025 at 22:15, 1 year 3 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The company is a biotechnology pioneer with disruptive therapeutic approaches. Visit www.nanobiotix.com for more info Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF published on 05/21/2025 at 22:20, 1 year 3 months ago Nanobiotix Reports Q1 2025 Achievements and Financial Status Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
Published on 09/19/2026 at 00:55, 1 day 5 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 1 day 8 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 10 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 1 day 16 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/20/2026 at 06:30, 17 minutes ago Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
Published on 09/20/2026 at 04:35, 2 hours 12 minutes ago How to Achieve Sustainable Power Without Changing Your Existing Backup System
Published on 09/19/2026 at 16:40, 14 hours 7 minutes ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/19/2026 at 13:15, 17 hours 33 minutes ago Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO
Published on 09/19/2026 at 07:30, 23 hours 18 minutes ago Hong Kong sets out initiatives to secure long-term development of pillar industries
Published on 09/18/2026 at 18:34, 1 day 12 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 2 days 13 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany